vs
Side-by-side financial comparison of Five9, Inc. (FIVN) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $300.3M, roughly 1.1× Five9, Inc.). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs 2.2%).
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
FIVN vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $300.3M | $336.6M |
| Net Profit | — | $13.5M |
| Gross Margin | 55.4% | 22.7% |
| Operating Margin | 6.6% | 5.3% |
| Net Margin | — | 4.0% |
| Revenue YoY | 7.8% | 2.2% |
| Net Profit YoY | — | 46.1% |
| EPS (diluted) | $0.22 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | $300.3M | $397.6M | ||
| Q3 25 | $285.8M | $377.4M | ||
| Q2 25 | $283.3M | $344.3M | ||
| Q1 25 | $279.7M | $329.3M | ||
| Q4 24 | $278.7M | — | ||
| Q3 24 | $264.2M | $314.4M | ||
| Q2 24 | $252.1M | — |
| Q1 26 | — | $13.5M | ||
| Q4 25 | — | $20.9M | ||
| Q3 25 | $18.0M | $9.8M | ||
| Q2 25 | $1.2M | $9.0M | ||
| Q1 25 | $576.0K | $9.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-4.5M | $-122.0M | ||
| Q2 24 | $-12.8M | — |
| Q1 26 | — | 22.7% | ||
| Q4 25 | 55.4% | 21.5% | ||
| Q3 25 | 55.0% | 19.8% | ||
| Q2 25 | 54.9% | 19.8% | ||
| Q1 25 | 55.0% | 19.5% | ||
| Q4 24 | 56.0% | — | ||
| Q3 24 | 53.8% | 19.4% | ||
| Q2 24 | 53.0% | — |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 6.6% | 7.7% | ||
| Q3 25 | 5.6% | 4.3% | ||
| Q2 25 | -0.6% | 3.7% | ||
| Q1 25 | -1.9% | 3.9% | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | -5.8% | -33.3% | ||
| Q2 24 | -7.7% | — |
| Q1 26 | — | 4.0% | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | 6.3% | 2.6% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 0.2% | 2.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.7% | -38.8% | ||
| Q2 24 | -5.1% | — |
| Q1 26 | — | $0.21 | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.21 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $0.16 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.1M | $64.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $785.8M | $232.4M |
| Total Assets | $1.8B | $426.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | $232.1M | $65.6M | ||
| Q3 25 | $193.4M | $36.5M | ||
| Q2 25 | $205.5M | $18.8M | ||
| Q1 25 | $370.3M | $14.0M | ||
| Q4 24 | $362.5M | — | ||
| Q3 24 | $291.0M | $37.2M | ||
| Q2 24 | $175.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | — |
| Q1 26 | — | $232.4M | ||
| Q4 25 | $785.8M | $217.9M | ||
| Q3 25 | $775.3M | $195.5M | ||
| Q2 25 | $717.4M | $179.7M | ||
| Q1 25 | $664.3M | $163.2M | ||
| Q4 24 | $622.2M | — | ||
| Q3 24 | $565.6M | $133.9M | ||
| Q2 24 | $525.9M | — |
| Q1 26 | — | $426.9M | ||
| Q4 25 | $1.8B | $412.7M | ||
| Q3 25 | $1.8B | $390.0M | ||
| Q2 25 | $1.7B | $356.3M | ||
| Q1 25 | $2.1B | $334.0M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | $348.0M | ||
| Q2 24 | $1.9B | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $6.1M |
| Free Cash FlowOCF − Capex | $77.3M | — |
| FCF MarginFCF / Revenue | 25.8% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | — | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | $201.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | $83.6M | $34.6M | ||
| Q3 25 | $59.2M | $28.2M | ||
| Q2 25 | $35.1M | $19.9M | ||
| Q1 25 | $48.4M | $17.6M | ||
| Q4 24 | $49.8M | — | ||
| Q3 24 | $41.1M | — | ||
| Q2 24 | $19.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $77.3M | — | ||
| Q3 25 | $48.7M | $24.2M | ||
| Q2 25 | $31.6M | — | ||
| Q1 25 | $43.7M | — | ||
| Q4 24 | $40.5M | — | ||
| Q3 24 | $26.7M | — | ||
| Q2 24 | $13.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 25.8% | — | ||
| Q3 25 | 17.0% | 6.4% | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 5.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 3.7% | 1.1% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 2.7% | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | 3.29× | 2.87× | ||
| Q2 25 | 30.38× | 2.21× | ||
| Q1 25 | 84.00× | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
